Ikeda Kei, Kambe Naotomo, Takei Syuji, Nakano Taiji, Inoue Yuzaburo, Tomiita Minako, Oyake Natsuko, Satoh Takashi, Yamatou Tsuyoshi, Kubota Tomohiro, Okafuji Ikuo, Kanazawa Nobuo, Nishikomori Ryuta, Shimojo Naoki, Matsue Hiroyuki, Nakajima Hiroshi
Arthritis Res Ther. 2014 Apr 8;16(2):R89. doi: 10.1186/ar4533.
Arthritis is the most frequent manifestation of Blau syndrome, an autoinflammatory disorder caused by the genetic mutation of NOD2. However, detailed information on arthritis in Blau syndrome on which the therapeutic strategy should be based on is lacking. This multi-center study aimed to accurately characterize the articular manifestation of Blau syndrome and also to demonstrate the utility of musculoskeletal ultrasound in Blau syndrome.
Patients who had been diagnosed with Blau syndrome by genetic analysis of NOD2 were recruited. A total of 102 synovial sites in 40 joints were assessed semiquantitatively by ultrasound for gray-scale synovitis and synovial power Doppler (PD) signal.
In total, 10 patients whose age ranged from 10 months to 37 years enrolled in this study. Although only 4 joints (0.8%) were tender on physical examination, 81 joints (16.9%) were clinically swollen. Moreover, 240 (50.0%), and 124 (25.8%) joints showed gray-scale (GS) synovitis and synovial PD signal on ultrasound, respectively. Importantly, GS synovitis was present in 168 out of 399 non-swollen joints, in which 61 also exhibited synovial PD signal. Among 40 joint regions, the ankle, the wrist, and the proximal interphalangeal joints were the most frequently and severely affected joints. Comparisons between different synovial tissues demonstrated a significantly higher proportion of the joints with tenosynovitis as compared with that with intra-articular synovitis (41.5% versus 27.9%, P < 0.0001). In respect of age and treatment, synovial PD signals were minimal in the youngest patient and in the oldest two patients, and were relatively mild in patients receiving treatment with methotrexate plus TNF antagonists. In two patients who underwent the second ultrasound examination, total PD scores markedly decreased after initiating the treatment with a tumor necrosis factor (TNF) antagonist.
The detailed information on synovial inflammation obtained by ultrasound confirms the dissociation between pain and inflammation and the frequently involved joint regions and synovial tissue in the arthritis of Blau syndrome. Our data also demonstrate that ultrasonography can be a potent tool in monitoring the activity of synovial inflammation and in investigating the pathophysiology of arthritis in this rare but archetypical autoinflammatory condition.
关节炎是布劳综合征最常见的表现,布劳综合征是一种由NOD2基因突变引起的自身炎症性疾病。然而,缺乏关于布劳综合征关节炎的详细信息,而治疗策略应基于这些信息。这项多中心研究旨在准确描述布劳综合征的关节表现,并证明肌肉骨骼超声在布劳综合征中的应用价值。
招募通过NOD2基因分析被诊断为布劳综合征的患者。通过超声对40个关节中的102个滑膜部位进行半定量评估,以检测灰阶滑膜炎和滑膜能量多普勒(PD)信号。
本研究共纳入10例年龄在10个月至37岁之间的患者。尽管体格检查时仅有4个关节(0.8%)有压痛,但临床上有81个关节(16.9%)肿胀。此外,超声检查分别显示240个(50.0%)和124个(25.8%)关节有灰阶(GS)滑膜炎和滑膜PD信号。重要的是,399个非肿胀关节中有168个存在GS滑膜炎,其中61个也表现出滑膜PD信号。在40个关节区域中,踝关节、腕关节和近端指间关节是最常受累且受累最严重的关节。不同滑膜组织之间的比较显示,腱鞘炎关节的比例显著高于关节内滑膜炎(41.5%对27.9%,P<0.0001)。在年龄和治疗方面,最年轻的患者和年龄最大的两名患者滑膜PD信号最少,接受甲氨蝶呤加肿瘤坏死因子拮抗剂治疗的患者滑膜PD信号相对较轻。在两名接受第二次超声检查的患者中,开始使用肿瘤坏死因子(TNF)拮抗剂治疗后,总PD评分明显下降。
通过超声获得的关于滑膜炎症的详细信息证实了布劳综合征关节炎中疼痛与炎症之间的分离以及经常受累的关节区域和滑膜组织。我们的数据还表明,超声检查可以成为监测滑膜炎症活动和研究这种罕见但典型的自身炎症性疾病中关节炎病理生理学的有力工具。